TABLE 1.
Name | Sequencea (5′-3′) | muIFN-β promoter position |
---|---|---|
Consensus | GA(C/g/a)(G/t)(C/a/t)CATN(T/a)(T/g/c) | |
32 | GCAGAAAGGACCATCCCTTATA | −32 coding strand |
32G | GCAGAAAGGgCCATCCCTTATA | −32 coding strand |
32T | GCAGAAAGGACCATCttTTATA | −32 coding strand |
32GT | GCAGAAAGGgCCATCttTTATA | −32 coding strand |
90 | TTTTCCTCTGTCATTTTCTCTT | −90 noncoding strand |
mut90 | TTTTCCTCTGTaATTTTCTCTT | −90 noncoding strand |
122 | CTTCTAATATTCATTTTATTCA | −122 noncoding strand |
mut122 | CTTCTAATATTgATTTTATTCA | −122 noncoding strand |
122G | CTTCTAATAgTCATTTTATTCA | −122 noncoding strand |
161 | TTAACCCAGTACATAGCATATA | −161 coding strand |
In the consensus sequence as defined by Hyde-DeRuyscher et al. (12) uppercase letters represent the preferred nucleotides and lowercase letters represent nucleotides tolerated to a lesser extent. Boldface letters indicate the nucleotides corresponding to the YY1 core motif. Underlining indicates the nucleotides present outside the core motif characterized as important for binding affinity and specificity. Lightface lowercase letters in the muIFN-β sites indicate mutations introduced in the sequence of the potential YY1-binding sites.